PAX5 and breast carcinoma: To expose some molecular mechanisms by which Pax-5 could suppress breast cancer aggressive features, we performed RT-qPCR on molecular mediators of breast cancer malignancy such as: MMP2 and MMP9; vimentin and fibronectin following Pax-5 transfection of MB231 cells.